Interestingly, variant carriage of the TLR4/rs5030728 A-allele has been associated with beneficial response to anti-TNF therapy among patients with IBD [73], implying that these patients may have a higher baseline activity or expression of TLR4. The gene discussed is TLR4; the disease is inflammatory bowel disease.